MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 


Receive this page by email each issue: [Sign up for eTOCs]

October 1995; 48 (4)   [Index by Author]       Other Issues:  
       Articles
Find articles in this issue containing these words:
[Search ALL Issues]


Table of Contents (PDF) | Editorial Board (PDF) | Front Matter (PDF) | Back Matter (PDF)
To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Articles:

EJ Kidd, CB Grahames, J Simon, AD Michel, EA Barnard, and PP Humphrey
Localization of P2X purinoceptor transcripts in the rat nervous system
Mol Pharmacol 1995 48: 569-573. [Abstract] [PDF]  

SA Forman, KW Miller, and G Yellen
A discrete site for general anesthetics on a postsynaptic receptor
Mol Pharmacol 1995 48: 574-581. [Abstract] [PDF]  

I Leduc, P Haddad, E Giasson, and S Meloche
Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells
Mol Pharmacol 1995 48: 582-592. [Abstract] [PDF]  

JM Thomas, JS Frazier, ZW Hu, and BB Hoffman
Phosphorylation of cyclic AMP response element-binding protein and induction of c-fos gene expression on withdrawal from chronic treatment with carbachol in NG108-15 cells
Mol Pharmacol 1995 48: 593-600. [Abstract] [PDF]  

B Lassegue, RW Alexander, G Nickenig, M Clark, TJ Murphy, and KK Griendling
Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation
Mol Pharmacol 1995 48: 601-609. [Abstract] [PDF]  

K Gradin, R Toftgard, and A Berghard
Differential effects of a topoisomerase I inhibitor on dioxin inducibility and high-level expression of the cytochrome P450IA1 gene
Mol Pharmacol 1995 48: 610-615. [Abstract] [PDF]  

R Alvarez, C Sette, D Yang, RM Eglen, R Wilhelm, ER Shelton, and M Conti
Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3
Mol Pharmacol 1995 48: 616-622. [Abstract] [PDF]  

M Popoli, C Vocaturo, J Perez, E Smeraldi, and G Racagni
Presynaptic Ca2+/calmodulin-dependent protein kinase II: autophosphorylation and activity increase in the hippocampus after long- term blockade of serotonin reuptake
Mol Pharmacol 1995 48: 623-629. [Abstract] [PDF]  

H Hellmold, JG Lamb, A Wyss, JA Gustafsson, and M Warner
Developmental and endocrine regulation of P450 isoforms in rat breast
Mol Pharmacol 1995 48: 630-638. [Abstract] [PDF]  

PJ Ciaccio, H Shen, AK Jaiswal, MH Lyttle, and KD Tew
Modulation of detoxification gene expression in human colon HT29 cells by glutathione-S-transferase inhibitors
Mol Pharmacol 1995 48: 639-647. [Abstract] [PDF]  

MA Desai, JP Burnett, NG Mayne, and DD Schoepp
Cloning and expression of a human metabotropic glutamate receptor 1 alpha: enhanced coupling on co-transfection with a glutamate transporter
Mol Pharmacol 1995 48: 648-657. [Abstract] [PDF]  

M Gupta, M Abdel-Megeed, Y Hoki, G Kohlhagen, K Paull, and Y Pommier
Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517
Mol Pharmacol 1995 48: 658-665. [Abstract] [PDF]  

KH Huh, TM Delorey, S Endo, and RW Olsen
Pharmacological subtypes of the gamma-aminobutyric acidA receptors defined by a gamma-aminobutyric acid analogue 4,5,6,7- tetrahydroisoxazolo[5,4-c] pyridin-3-ol and allosteric coupling: characterization using subunit-specific antibodies
Mol Pharmacol 1995 48: 666-675. [Abstract] [PDF]  

Z Pei, TP Calmels, CE Creutz, and SM Sebti
Yeast cysteine proteinase gene ycp1 induces resistance to bleomycin in mammalian cells
Mol Pharmacol 1995 48: 676-681. [Abstract] [PDF]  

UG Bhat, MA Winter, HL Pearce, and WT Beck
A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P- glycoprotein in a human colon carcinoma cell line
Mol Pharmacol 1995 48: 682-689. [Abstract] [PDF]  

N Yabaluri and F Medzihradsky
Reversible modulation of opioid receptor binding in intact neural cells by endogenous guanosine triphosphate
Mol Pharmacol 1995 48: 690-695. [Abstract] [PDF]  

J Proska and S Tucek
Competition between positive and negative allosteric effectors on muscarinic receptors
Mol Pharmacol 1995 48: 696-702. [Abstract] [PDF]  

B Lanier, R Raddatz, V Bakthavachalam, I Coupry, JL Neumeyer, and SM Lanier
Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit
Mol Pharmacol 1995 48: 703-710. [Abstract] [PDF]  

FZ Chung, LH Wu, Y Tian, MA Vartanian, H Lee, J Bikker, C Humblet, MC Pritchard, J Raphy, and N Suman-Chauhan
Two classes of structurally different antagonists display similar species preference for the human tachykinin neurokinin3 receptor
Mol Pharmacol 1995 48: 711-716. [Abstract] [PDF]  

AL Buller, HC Larson, RA Morrisett, and DT Monaghan
Glycine modulates ethanol inhibition of heteromeric N-methyl-D- aspartate receptors expressed in Xenopus oocytes
Mol Pharmacol 1995 48: 717-723. [Abstract] [PDF]  

SA McCormack, BJ Zimmerman, M Israel, P Blanner, and LR Johnson
Structural requirements of analogues of polyamines for migration and growth of IEC-6 cells
Mol Pharmacol 1995 48: 724-729. [Abstract] [PDF]  

ZH Qin, LW Zhou, SP Zhang, Y Wang, and B Weiss
D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors
Mol Pharmacol 1995 48: 730-737. [Abstract] [PDF]  

C Chavany, Y Connell, and L Neckers
Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers
Mol Pharmacol 1995 48: 738-746. [Abstract] [PDF]  

PM Seldon, PJ Barnes, K Meja, and MA Giembycz
Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase
Mol Pharmacol 1995 48: 747-757. [Abstract] [PDF]  

G Chen, JE Wright, and A Rosowsky
Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells
Mol Pharmacol 1995 48: 758-765. [Abstract] [PDF]  

M Nogami, SM Whittle, DJ Romberger, SI Rennard, and ML Toews
Lysophosphatidic acid regulation of cyclic AMP accumulation in cultured human airway smooth muscle cells
Mol Pharmacol 1995 48: 766-773. [Abstract] [PDF]  

V Gerzanich, X Peng, F Wang, G Wells, R Anand, S Fletcher, and J Lindstrom
Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors
Mol Pharmacol 1995 48: 774-782. [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
The Journal of Pharmacology and Experimental 
Therapeutics Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics